Diversity and plasticity of self recognition during the development of multiple sclerosis.
Open Access
- 1 April 1997
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 99 (7) , 1682-1690
- https://doi.org/10.1172/jci119331
Abstract
Recent studies using murine animal model systems indicate that clinical progression of autoimmune disease may be due to the sequential accumulation of neoautoreactivity characterized by extensive plasticity of self recognition. In the present study, we addressed the question of whether a similar paradigm of self recognition is implicated in the development of multiple sclerosis (MS), a demyelinating disease with a presumed autoimmune etiology. Our approach was to determine serial changes over a 12-18-mo period in response to an epitope-mapping series of 265 12-mer peptides of myelin proteolipid protein (PLP) by patients with isolated monosymptomatic demyelinating syndromes (IMDS), a group of distinct clinical disorders with variable rates of progression to MS. Our data showed that an extensive array of proteolipid protein peptides could elicit autoreactivity. Moreover, differential autoreactive patterns were evident within IMDS patient subpopulations. Monocentric monophasic IMDS patients with no evidence of prior subclinical disease typically showed fully sustained autoreactivity characterized by extensive plasticity, epitope focusing, shifting, and spreading of responses to new self determinants. In contrast, multicentric monophasic IMDS patients with putative evidence of prior asymptomatic lesion formation typically showed partially sustained autoreactivity characterized by abrupt abrogation of responses to an extensive array of self determinants. No sustained autoreactivity was observed in normal control subjects or in patients with other neurologic diseases. Our results indicate that self recognition associated with the development of MS is a developmental process characterized by autoreactive diversity, plasticity, and instability.Keywords
This publication has 49 references indexed in Scilit:
- Multiple Sclerosis: A Coordinated Immunological Attack against Myelin in the Central Nervous SystemCell, 1996
- Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic proteinNature, 1996
- T cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelitisEuropean Journal of Immunology, 1994
- Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 allelesHuman Immunology, 1994
- Development of Reactivity to New Myelin Antigens during Chronic Relapsing Autoimmune DemyelinationCellular Immunology, 1993
- Immunological Aspects of Demyelinating DiseasesAnnual Review of Immunology, 1992
- T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosisNature, 1990
- T Cells Responsive to Myelin Basic Protein in Patients with Multiple SclerosisScience, 1990
- Antigenicity of MyohemerythrinScience, 1987
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983